On the basis of this evidence, we screened all TP53 coding exons for mutations and assessed LOH at the TP53 locus in a subset of benign and malignant salivary gland neoplasms and performed p53 immunohistochemistry on the samples. The gene discussed is TP53; the disease is salivary gland cancer.